Upadacitinib demonstrated long-term efficacy for the treatment of ankylosing spondylitis among patients who failed to respond ...

It’s two years since Novartis got its Cosentyx IL-17 drug approved for the spinal disease ankylosing spondylitis, and the Swiss pharma company has new data that it hopes will allow it to compete ...

The term ankylosing spondylitis describes the process of bone fusion and subsequent typical forward-bending spinal deformity (ankylosis) driven by pathological new bone formation (ie, structural ...

Patient physical function is probably the most relevant outcome parameter in ankylosing spondylitis and ... and the level of structural damage of the spine as determined by the mSASSS method.

The Department for Work and Pensions (DWP) has confirmed that over 1.1 million adults across Great Britain are now receiving ...

the modified Stokes Ankylosing Spondylitis Spinal Score, Radiographic Ankylosing Spondylitis Spinal Score or the PsA Spondylitis Radiology Index. The PsA Ratingen Score and the PsA Spondylitis ...

Objectives: Given the involvement of the IL-17 pathway and overlap in symptoms in psoriasis and ankylosing spondylitis (AS), we conducted a phase 2/3 trial to evaluate the efficacy and safety of ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Axial spondyloarthritis ...

The Department for Work and Pensions (DWP) has said that over 1.1 million adults across Great Britain are now receiving ...